Table 1 Characteristics of patient population.

Characteristic	T1D (n=811)	T2D (n=1 619)
Number of patients who completed part 2 SAQ, n (%)	641 (79.0)	1 415 (87.4)
Sex male/female, %	51/49	54/46
Mean age, years (SD)	47.8 (14.7)	66.3 (10.5)
Duration of diabetes, years (SD)	19.9 (12.8)	15.4 (8.8)
HbA 1c , mmol/mol (SD)	59.6 (13.8)	58.3 (13.6)
HbA 1c , %*	7.6	7.5
Method of diabetes treatment, n (%)
Short-acting insulin	671 (82.9)	1 237 (77.0)
Long-acting insulin	517 (63.9)	1 348 (83.9)
Mixed insulin	7 (0.9)	129 (8.0)
Insulin pump	228 (28.2)	15 (0.9)
Oral antidiabetes treatments	17 (2.1)	449 (27.9)
Injectable antidiabetes treatments excluding insulin	0 (0.0)	27 (1.7)
Checks blood sugar levels, n (%)
Yes	806 (99.4)	1 597 (98.8)
No	5 (0.6)	20 (1.2)
Experienced hypoglycaemia, n (%)
Yes	780 (97.1)	1 224 (76.3)
No	13 (1.6)	322 (20.1)
Not sure	10 (1.2)	58 (3.6)

* Calculated, not measured. Full analysis set; SAQ, self-assessment questionnaire; SD, standard deviation; T1D, type 1 diabetes; T2D, type 2 diabetes